Lipe & Dalton’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $192K | Hold |
|
|||||
|
2024
Q3 | $283K | Hold |
|
|||||
|
2024
Q2 | $283K | Hold |
|
|||||
|
2024
Q1 | $259K | Hold |
|
|||||
|
2023
Q4 | $236K | Hold |
|
|||||
|
2023
Q3 | $221K | Hold |
|
|||||
|
2023
Q2 | $193K | Sell |
|
|||||
|
2023
Q1 | $237K | Hold |
|
|||||
|
2022
Q4 | $209K | Sell |
|
|||||
|
2022
Q3 | $213K | Hold |
|
|||||
|
2022
Q2 | $183K | Hold |
|
|||||
|
2022
Q1 | $216K | Hold |
|
|||||
|
2021
Q4 | $195K | Buy |
|
|||||
|
2021
Q3 | $126K | Hold |
|
|||||
|
2021
Q2 | $117K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $478K | Buy |
|
|||||
|
2019
Q3 | $326K | Buy |
|
|||||
|
2019
Q2 | $302K | Buy |
|
|||||
|
2019
Q1 | $338K | Buy |
|